CLINICAL_TRIALS
trial_result
· 2015-05-21
Clinical Trial Update: Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics [Phase 3]
Summary
Phase 3 study assessing the efficacy of inhaled albuterol Spiromax in subjects with persistent asthma; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2015-05-21